S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)

Natus Medical Stock Forecast, Price & News

-0.25 (-1.03%)
(As of 01/14/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
172,440 shs
Average Volume
148,380 shs
Market Capitalization
$817.60 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive NTUS News and Ratings via Email

Sign-up to receive the latest news and ratings for Natus Medical and its competitors with MarketBeat's FREE daily newsletter.

Natus Medical logo

About Natus Medical

Natus Medical, Inc. provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. Its products are used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company was founded by Maurizio Liverani, John Robert Camber Porter, William New, Jr., Brian Prinn and William W. Moore on May 26, 1987 and is headquartered in Pleasanton, CA.


See More Headlines

Industry, Sector and Symbol

Electromedical equipment
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$415.68 million
Cash Flow
$1.22 per share
Book Value
$12.14 per share


Net Income
$-16.61 million
Pretax Margin




Free Float
Market Cap
$817.60 million

Company Calendar

Last Earnings
Next Earnings (Confirmed)
Fiscal Year End


Overall MarketRank

1.54 out of 5 stars

Medical Sector

1066th out of 1,417 stocks

Electromedical Equipment Industry

19th out of 30 stocks

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.9 5 -4 -3 -2 -1 -

Natus Medical (NASDAQ:NTUS) Frequently Asked Questions

How has Natus Medical's stock price been impacted by COVID-19 (Coronavirus)?

Natus Medical's stock was trading at $27.18 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NTUS stock has decreased by 11.9% and is now trading at $23.94.
View which stocks have been most impacted by COVID-19

When is Natus Medical's next earnings date?

Natus Medical is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for Natus Medical

How can I listen to Natus Medical's earnings call?

Natus Medical will be holding an earnings conference call on Friday, February 25th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 404-537-3406 with passcode "6682846".

How were Natus Medical's earnings last quarter?

Natus Medical Incorporated (NASDAQ:NTUS) announced its earnings results on Thursday, November, 4th. The company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.30 by $0.02. The company had revenue of $113.88 million for the quarter, compared to analysts' expectations of $116.60 million. Natus Medical had a net margin of 3.59% and a trailing twelve-month return on equity of 9.07%. During the same period last year, the business posted $0.09 earnings per share.
View Natus Medical's earnings history

What guidance has Natus Medical issued on next quarter's earnings?

Natus Medical issued an update on its FY 2021 earnings guidance on Thursday, December, 2nd. The company provided earnings per share (EPS) guidance of $1.130-$1.180 for the period. The company issued revenue guidance of $468.80 million-$472.80 million, compared to the consensus revenue estimate of $472 million.

Who are Natus Medical's key executives?

Natus Medical's management team includes the following people:
  • Seán Langan, Vice President-Global Operations
  • Benjamin Drew Davies, Chief Financial Officer & Executive Vice President
  • D. Christopher Chung, Chief Medical Officer & VP-Regulatory Affairs
  • Ivan Pandiyan, Vice President-Research & Development
  • Austin Francis Noll, Chief Commercial Officer & Executive VP

What other stocks do shareholders of Natus Medical own?

What is Natus Medical's stock symbol?

Natus Medical trades on the NASDAQ under the ticker symbol "NTUS."

Who are Natus Medical's major shareholders?

Natus Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Tributary Capital Management LLC (1.63%), Confluence Investment Management LLC (0.54%) and State of Alaska Department of Revenue (0.07%). Company insiders that own Natus Medical stock include Alice D Schroeder, Dong Chune Christopher Chung and Lisa Wipperman Heine.
View institutional ownership trends for Natus Medical

Which major investors are selling Natus Medical stock?

NTUS stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have sold Natus Medical company stock in the last year include Alice D Schroeder, and Dong Chune Christopher Chung.
View insider buying and selling activity for Natus Medical
or view top insider-selling stocks.

Which major investors are buying Natus Medical stock?

NTUS stock was bought by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC, and Confluence Investment Management LLC.
View insider buying and selling activity for Natus Medical
or or view top insider-buying stocks.

How do I buy shares of Natus Medical?

Shares of NTUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Natus Medical's stock price today?

One share of NTUS stock can currently be purchased for approximately $23.94.

How much money does Natus Medical make?

Natus Medical has a market capitalization of $817.60 million and generates $415.68 million in revenue each year. The company earns $-16.61 million in net income (profit) each year or $0.48 on an earnings per share basis.

How many employees does Natus Medical have?

Natus Medical employs 1,420 workers across the globe.

What is Natus Medical's official website?

The official website for Natus Medical is www.natus.com.

Where are Natus Medical's headquarters?

How can I contact Natus Medical?

Natus Medical's mailing address is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. The company can be reached via phone at (925) 223-6700, via email at [email protected], or via fax at 650-802-0401.

This page was last updated on 1/17/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.